WebAug 31, 2024 · Periodic screening for iron deficiency and the use of Ferinject® to reduce hospitalisation rates and improve HF symptoms are now recommended; In addition, Veltassa® (patiromer) is newly proposed to enable the use of renin-angiotensin aldosterone system inhibitor (RAASi) in patients with hyperkalemia ... WebFeb 17, 2024 · ST. GALLEN, Switzerland--(BUSINESS WIRE)-- Regulatory News:AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR. Vifor Pharma Group reported a solid performance in 2024 and an increase in profitability, supported by a strong recovery in Ferinject ® / Injectafer ® sales from the second quarter 2024 on, and sustained by …
FERINJECT 50MG IRON/ML SOLUTION FOR INJECTION/INFUSION
WebAug 27, 2007 · Ferinject® will be administered in doses of 200 mg (4 mL) weekly up to iron repletion (correction phase of variable duration depending on individual iron deficit). The calculated dose will be rounded to the next 100 mg iron, i.e. the final dose may be 100 mg iron depending on the individual iron deficit. WebMar 31, 2024 · The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. Last updated on emc: 27 Mar 2024. View or print the patient leaflet as PDF. Vifor Pharma UK Limited. shanxi huojia changhua synthetic rubber
intravenous ferric carboxymaltose - bpac
WebApr 4, 2024 · Ferinject (ferric carboxymaltose) Active Ingredient: Ferric carboxymaltose Company: Vifor Pharma UK Limited See contact details ATC code: B03AC About … WebJun 17, 2024 · N.B. Ferric carboxymaltose (Ferinject) is suitable for administration in a primary care setting and is funded with Special Authority approval for patients with iron deficiency anaemia (i.e. low haemoglobin) with a serum ferritin of ≤ 20 micrograms/L, and oral iron treatment has proven ineffective or resulted in dose-limiting intolerance or rapid … WebNov 28, 2024 · Ferinject® has now received marketing authorization in 85 countries worldwide. “We are thrilled about the marketing authorization of Ferinject®, which is a milestone for Chinese patients living with iron deficiency or iron deficiency anemia”, said Hervé Gisserot, General Manager of CSL Vifor. shanxi installation group